# FDA recall D-0508-2021

> **Cardinal Health Inc.** · Class II · drug recall initiated 2021-03-15.

## Product

TRI-LO-MARZIA  0.180MG/0.025MG; 0.215 MG/0.025MG AND 0.250MG/0.025MG 3X28 BPK; NDC/UPC 68180-837-73; RX; TABLETS

## Reason for recall

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

## Distribution

FL, GA, SC

## Key facts

- **Recall number:** D-0508-2021
- **Recalling firm:** Cardinal Health Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-03-15
- **Report date:** 2021-06-02
- **Termination date:** 2024-06-17

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Dublin, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0508-2021

## Citation

> AI Analytics. FDA recall D-0508-2021. Retrieved 2026-07-10 from https://api.ai-analytics.org/recall/D-0508-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*